PERTH, Australia – Neuroscience technology company Cogstate Ltd. and Japanese pharmaceutical company Eisai Co. Ltd. signed a deal under which Eisai will have global development rights and exclusive ...

Melbourne, VIC, Australia; New Haven, CT, USA, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Cogstate (COGZF), a leading neuroscience technology company, today announced the ...

PERTH, Australia – Digital cognitive assessment technology company Cogstate Ltd. saw its stock skyrocket 60% on the heels of FDA accelerated approval of Biogen Inc./Eisai Co. Ltd.’s Alzheimer’s ...

Cogstate Ltd (AU:CGS) has released an update. Cogstate Ltd, a leader in neuroscience technology, continues to enhance brain health assessments through cutting-edge cognitive testing and eCOA solutions ...

Objective To determine potential changes in cognitive function over the course of a contact hockey season in asymptomatic youth. Design Cohort study, repeated measures. Setting Youth hockey ice rink, ...

This article was produced in partnership with the Davos Alzheimer’s Collaborative by Scientific American Custom Media, a division separate from the magazine’s board of editors. Any primary care ...

Central nervous system (CNS) clinical trials are among the most scientifically complex and operationally demanding in life sciences. The need to evaluate nuanced cognitive, behavioral, and emotional ...

Cogstate Ltd. is a global cognitive science company, which engages in delivering software services to optimize the measurement of cognition in clinical trials, academic research, healthcare and brain ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cogstate Ltd ( (AU:CGS)) has provided an ...